[ 1 ] Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus[J]. Gut, 2013, 62(1): 102-111.
[2]
[ 2 ] Yousaf M, Mccallion K, Diamond T. Management of severe acute pancreatitis[J]. Br J Surg, 2003, 90(4): 407-420.
[3]
[ 3 ] Dambrauskas Z, Gulbinas A, Pundzius J, et al. Meta-analysis of prophylactic parenteral antibiotic use in acute necrotizing pancreatitis[J]. Medicina (Kaunas), 2007, 43(4): 291-300.
[4]
[ 4 ] Lavrentieva A, Papadopoulou S, Kioumis J, et al. PCT as a diagnostic and prognostic tool in burn patients. Whether time course has a role in monitoring sepsis treatment[J]. Burns, 2012, 38(3): 356-363.
[5]
Meisner M, Müller V, Khakpour Z, et al. Induction of procalcitonin and proinflammatory cytokines in an anhepatic baboon endotoxin shock model[J]. Shock, 2003, 19(2): 187-190.
[6]
Riché FC, Cholley BP, Laisné MJ, et al. Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis[J]. Surgery, 2003, 133(3): 257-262.
[7]
Mofidi R, Suttie SA, Patil PV, et al. The value of procalcitonin at predicting the severity of acute pancreatitis and development of infected pancreatic necrosis: systematic review[J]. Surgery, 2009, 146(1): 72-81.
[8]
Rau BM, Kemppainen EA, Gumbs AA, et al. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study[J]. Ann Surg, 2007, 245(5): 745-754.
Oláh A, Belágyi T, Issekutz A, et al. Value of procalcitonin quick test in the differentiation between sterile and infected forms of acute pancreatitis[J]. Hepatogastroenterology, 2005, 52(61): 243-245.
[11]
Schuetz P, Amin DN, Greenwald JL. Role of procalcitonin in managing adult patients with respiratory tract infections[J]. Chest, 2012, 141(4): 1063-1073.
[12]
Schroeder S, Hochreiter M, Koehler T, et al. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study[J]. Langenbecks Arch Surg, 2009, 394(2): 221-226.
[13]
Altunhan H, Annagür A, ？rs R, et al. Procalcitonin measurement at 24 hours of age maybe helpful in the prompt diagnosis of early-onset neonatal sepsis[J]. Int J Infect Dis, 2011, 15(12): 854-858.
[14]
Fritz S, Hartwig W, Lehmann R, et al. Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis[J]. Crit Care, 2008, 12(6): R141.
[15]
Jiang K, Huang W, Yang XN, et al. Present and future of prophylactic antibiotics for severe acute pancreatitis[J]. World J Gastroenterol, 2012, 18(3): 279-284.
[16]
De Waele JJ. A role for prophylactic antibiotics in necrotizing pancreatitis Why we may never know the answer[J]. Crit Care, 2008, 12(6): 195.
[17]
Qu R, Ji Y, Ling Y, et al. Procalcitonin is a good tool to guide duration of antibiotic therapy in patients with severe acute pancreatitis. A randomized prospective single-center controlled trial[J]. Saudi Med J, 2012, 33(4): 382-387.
[18]
Dambrauskas Z, Gulbinas A, Pundzius J, et al. Value of routine clinical tests in predicting the development of infected pancreatic necrosis in severe acute pancreatitis[J]. Scand J Gastroenterol, 2007, 42(10): 1256-1264.
[19]
[ 5 ] Cheval C, Timsit JF, Garrouste-Orgeas M, et al. Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients[J]. Intensive Care Med, 2000, 26(Suppl 2): S153-S158.
[20]
[ 6 ] Haasper C, Kalmbach M, Dikos GD, et al. Prognostic value of procalcitonin (PCT) and/or interleukin-6 (IL-6) plasma levels after multiple trauma for the development of multi organ dysfunction syndrome (MODS) or sepsis[J]. Technol Health Care, 2010, 18(2): 89-100.
[21]
[ 7 ] Nakamura A, Wada H, Ikejiri M, et al. Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit[J]. Shock, 2009, 31(6): 586-591.
[22]
[ 8 ] Snider JH, Nylen ES, Becker KL. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization[J]. J Investig Med, 1997, 45(9): 552-560.
[23]
[ 9 ] Morgenthaler NG, Struck J, Chancerelle Y, et al. Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection[J]. Horm Metab Res, 2003, 35(5): 290-295.
[24]
Kyl？np？？-B？ck ML, Takala A, Kemppainen EA, et al. Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis[J]. Crit Care Med, 2001, 29(1): 63-69.
[25]
Watkins RR, Lemonovich TL. Serum procalcitonin in the diagnosis and management of intra-abdominal infections[J]. Expert Rev Anti Infect Ther, 2012, 10(2): 197-205.
Nylen ES, Whang KT, Snider RH, et al. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis[J]. Crit Care Med, 1998, 26(6): 1001-1006.
[28]
Yonetci N, Sungurtekin U, Oruc N, et al. Is procalcitonin a reliable marker for the diagnosis of infected pancreatic necrosis[J]. ANZ J Surg, 2004, 74(7): 591-595.
